| CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
| 110406-83-2 | | 1(2h)-phthalazinone, 4-((4-fluorophenyl)methyl)-2-(hexahydro-1-(2-(3-(trifluoro | | | | |
| 110406-94-5 | | azelastine impurity b | | | | |
| 110407-58-4 | 5-羟基-2-羧酸乙酯 | ethyl 5-hydroxyoxane-2-carboxylate | | | | |
| 110407-59-5 | 1-溴-2-氯-4-氟苯 | 1-bromo-2-chloro-4-fluorobenzene | | | | |
| 1104070-94-1 | | phthalazine-5-carboxylic acid | | | | |
| 1104071-55-7 | | 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]isothiazole | | | | |
| 1104072-57-2 | | (S)-3-boc-4-(4-chlorobenzyl)-1,2,3-oxathiazolidine 2,2-dioxide | | | | |
| 1104074-27-2 | | 2-(1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2h-isoindol-2-yl)-3-phenylpropanoic acid | | | | |
| 1104076-62-1 | | h2n-peg24-ch2ch2cootbu | | | | |
| 1104077-35-1 | (2S)-1-(吡啶-2-基)吡咯烷-2-羧酸 | (2S)-1-(pyridin-2-yl)pyrrolidine-2-carboxylic acid | | | | |
| 1104083-23-9 | | 1-boc-3-hydroxy-3-methylazetidine | | | | |
| 1104083-27-3 | | 1-boc-3-hydroxy-3-methylpiperidine | | | | |
| 1104083-46-6 | | h2n-peg6-ch2cooh | | | | |
| 11041-12-6 | 考来烯胺 | cholestyramine | | | | |
| 11041-92-2 | | hexasalicylidene-neomyci | | | | |
| 11041-94-4 | | 7-isoquinolinediol, 1,2,3,4-tetrahydro-1-((4-hydroxyphenyl)methyl)- hydrochl | | | | |
| 110417-88-4 | | dolastatin 10 | | | | |
| 110419-21-1 | | 1,3-dinitro-fluoranthen | | | | |
| 1104196-18-0 | | tert-butyl 3-[(prop-2-en-1-yl)amino]propanoate | | | | |
| 11042-62-9 | | ochramycin | | | | |
| 11042-64-1 | 谷维素 | .gamma.-Orizanol | C40H58O4 | | | |
| 110422-17-8 | | n-(1,1,4-trimethylpentyl)-4-morpholineacetamid hydrochloride | | | | |
| 110423-62-6 | | 3-(2-methylpiperidino)-butyranilide hydrochloride | | | | |
| 1104243-87-9 | | ethyl 3-(1-methyl-1h-pyrazol-4-yl)-3-oxopropanoate | | | | |
| 110425-23-5 | | 1(2h)-phthalazinone, 4-((4-chlorophenyl)methyl)-2-(hexahydro-1-(3-(4-methylphen | | | | |
| 110425-24-6 | | 2-(1-(2-(4-fluorophenyl)ethyl)hexahydro-1h-azepin-4-yl)-4-1(2h)-phthalazinon | | | | |
| 110427-00-4 | | ethyl 2-methyl-3-(methylamino)propanoate | | | | |
| 110427-52-6 | | 1-imidazolidineacetic acid, 2,5-dioxo-4,4-diphenyl-3-(2-hydroxy-3-(4-(phenylmet | | | | |
| 110427-55-9 | | 2,4-imidazolidinedione, 5,5-diphenyl-3-ethyl-1-(2-hydroxy-3-(1-piperidinyl)prop | | | | |
| 1104276-25-6 | | 4-ethyl-2-pyrimidin-2-yl-1,3-thiazole-5-carboxylic acid | | | | |
| 1104276-29-0 | 4-甲基-2-(2-嘧啶基)噻唑-5-羧酸 | 4-methyl-2-(2-pyrimidinyl)thiazole-5-carboxylic acid | | | | |
| 110429-35-1 | 盐酸帕罗西汀 半水合物 | paroxetine hydrochloride hemihydrate | | | | |
| 110429-36-2 | 甲基帕罗西汀 | | | | | |
| 110429-45-3 | 三乙二醇2-溴乙基甲醚 | triethylene glycol 2-bromoethyl methyl ether | | | | |
| 11043-89-3 | | suitamycin | | | | |
| 11043-90-6 | | tipol | | | | |
| 11043-98-4 | | mitocromin | | | | |
| 11043-99-5 | | mitomalcin | | | | |
| 110431-65-7 | | benzenehexathiol hexasodium salt | C6Na6S6 | 402.36 | | |
| 110435-59-1 | | 10-(3-(4-ethyl-1-piperazinyl)propyl)-phenothiazin | | | | |
| 110435-78-4 | | 5,5-diphenyl-3-[2-(1-pyrrolidinyl)ethyl]-2,4-imidazolidinedione | | | | |
| 110436-24-3 | | 10-(2-(4-ethyl-1-piperazinyl)propyl)-phenothiazin | | | | |
| 110437-09-7 | | anthranilic acid, n-(2,3-bis(diethylamino)propionyl)-, ethyl ester, dihydrochlo | | | | |
| 1104376-15-9 | 2-甲基-6-(4-甲基哌嗪-1-基)嘧啶-4-胺 | 2-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-4-amine | | | | |
| 110438-25-0 | | titanium, [2,2-bis[(2-propenyloxy)methyl]-1-butanolato-o,o',o'']tris(dioctyl ph | | | | |
| 110438-26-1 | | piperazine, polymer with (chloromethyl)oxirane, compd. with (chloromethyl)benze | | | | |
| 110438-27-2 | | polymer with alpha-(4-aminobenzolyl)- omega -[(4-3-benzenedicarboxylic acid | | | | |
| 110438-99-8 | | n-tert-butyl-2-(diethylamino)-acetamid hydrochloride | | | | |
| 1104383-06-3 | 3,3-二甲基-4-boc-2-哌嗪酮 | 4-boc-3,3-dimethyl-2-piperazinone | | | | |
| 1104383-68-7 | 2-甲基-6-三氟甲基苯甲酸 | 2-methyl-6-trifluoromethylbenzoic acid | | | | |
m.cnreagent.com